EXOTHERA Revenue and Competitors
Estimated Revenue & Valuation
- EXOTHERA's estimated annual revenue is currently $35.2M per year.
- EXOTHERA's estimated revenue per employee is $155,000
Employee Data
- EXOTHERA has 227 Employees.
- EXOTHERA grew their employee count by 8% last year.
EXOTHERA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | MarCom Business Partner at EXOTHERA | Reveal Email/Phone |
EXOTHERA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 32 | -26% | N/A | N/A |
#2 | $510.1M | 1097 | 31% | $2B | N/A |
#3 | $13.6M | 88 | 44% | N/A | N/A |
#4 | $12.2M | 79 | 0% | N/A | N/A |
#5 | $28.7M | 185 | 5% | N/A | N/A |
#6 | $35.2M | 227 | 8% | N/A | N/A |
#7 | $4M | 26 | -10% | N/A | N/A |
#8 | $10.9M | 70 | 23% | N/A | N/A |
#9 | $10.4M | 67 | 24% | N/A | N/A |
#10 | $6.2M | 40 | 29% | N/A | N/A |
What Is EXOTHERA?
Exothera is a viral vector contract manufacturing and development organization (CDMO) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.
keywords:N/A
N/A
Total Funding
227
Number of Employees
$35.2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EXOTHERA News
The scale-up manufacturing process will leverage Exothera's expertise using the NevoLi-ne Upstream platform (integrating the intensified...
ReiThera and Exothera are partnering to develop what they call a large-scale, low cost per dose manufacturing process to deliver novel...
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and...
Other Companies in Nivelles
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35.2M | 227 | 8% | N/A |
#2 | $116.4M | 642 | 4% | N/A |